Gallant Pet
San Diego, US · Founded 2018 · Delaware corporation · 8 known investors
Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.
Founders & leadership
LB

Linda BlackChief Executive Officer, Chief Financial Officer & Secretary
AH
Aaron HirschhornExecutive Officer, Director
DB
Davis BrimerExecutive Officer, Director
TB

Teymour Boutros-GhaliDirector
VW
Valentine WilliamsDVM, MS, Diplomate ACVS
AS

Aaron SchachtDirector
DR

Darryl RawlingsDirector
RJ
Richard JenningsDirector
JR
James RatiganDirector
Investors · 8
Alpha EdisonLos Angeles · $1M – $10M
Baroda VenturesLos Angeles · $100K – $5M
Bling CapitalMiami Beach · $1M – $5M
Bold Capital PartnersSanta Monicavia Teymour Boutros-Ghali · board
Expansion Venture CapitalNew York · $250K – $1M
MaveronSeattle · $5M – $10M
Western Technology InvestmentPortola Valley · $250K – $30M
Digitalis VenturesreportedNew York · $100K – $10Mvia Misti Ushio · board
Reported raises · per SEC filings
Form D private placements▶$10.2MraisedJul 2025 · 22 investors · OtherRule 506(b)
▶$10.2MraisedJul 2025 · 22 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Misti UshioDirector
- Doug DrewDirector
- Teymour Boutros-GhaliDirector
- Aaron SchachtDirector
- Richard JenningsDirector
- Darryl RawlingsDirector
- Linda BlackExecutive Officer, Director
- Offering amount
- $18M
- Amount sold
- $10.2M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.5MraisedAug 2024 · 87 investors · OtherRule 506(b)
▶$25.5MraisedAug 2024 · 87 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Aaron SchachtDirector
- Darryl RawlingsDirector
- Linda BlackExecutive Officer, Director
- Teymour Boutros-GhaliDirector
- Richard JenningsDirector
- James RatiganDirector
- Offering amount
- $27.1M
- Amount sold
- $25.5M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedAug 2019 · 24 investors · OtherRule 506(b)
▶$7MraisedAug 2019 · 24 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Aaron HirschhornExecutive Officer, Director
- Davis BrimerExecutive Officer, Director
- Darryl RawlingsDirector
- Offering amount
- $7M
- Amount sold
- $7M
- Minimum investment
- $1
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Gallant Pet — BOLD Capital Partnersboldcapitalpartners.com · 2021
- Gallant Pet Raises $7 Million to Store Canine Stem Cells - Los Angeles Business Journallabusinessjournal.com · 2019